How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | NDSNNORDSON CORP | DOVDOVER Corp | XYLXylem Inc. | SYMSymbotic Inc. | Median of the restexcluding NDSN |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $318.71▼ 12.83 (3.87%) | $199.84▲ 2.70 (1.37%) | $106.35▲ 1.33 (1.27%) | $40.36▼ 1.37 (3.28%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 9.0/10 | 9.0/10 | 9.0/10 | 6.0/10 | 9.0/10 |
| Market value | $17.82B | $27.42B | $25.91B | $23.85B | |
| Revenue | $2.79B | $8.09B | $9.04B | $2.25B | |
| Profit | $484.5M | $1.09B | $957.0M | -$16.9M | |
| Revenue growthChange in sales versus the prior year. | 3.8% | 4.5% | 5.5% | 25.7% | 5.5% |
| Gross marginShare of sales left after the direct cost of producing them. | 55.2% | 39.8% | 38.5% | 18.8% | 38.5% |
| Operating marginShare of sales left after running the business, before interest and tax. | 25.5% | 17.0% | 13.5% | -5.1% | 13.5% |
| Profit marginProfit kept from each dollar of sales. | 17.4% | 13.5% | 10.6% | -0.8% | 10.6% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 23.7% | 13.8% | 10.1% | — | 11.9% |
| Return on equityProfit against the owners' stake in the company. | 15.9% | 14.8% | 8.3% | -7.7% | 8.3% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 11.7% | 12.1% | 8.3% | — | 10.2% |
| P/E ratioPrice paid per dollar of annual profit. | 36.79x | 25.07x | 27.07x | — | 26.07x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 24.92x | 16.59x | 14.67x | — | 15.63x |
| Price to book | 5.86x | 3.70x | 2.26x | 107.76x | 3.70x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.94x | 0.81x | 0.51x | 8.67x | 0.81x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 7/9 | 6/9 | 7/9 | 4/8 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | safe | safe | safe | safe |
How NDSN compares with the others
- NDSN's operating margin of 25.5% is higher than the median of the other companies selected (13.5%).
- Its revenue growth of 3.8% is in line with the median of the other companies selected (5.5%).
- It trades at a higher P/E than the median of the other companies selected: 36.8x against 26.1x.
- Its liabilities are higher relative to equity than the median of the other companies selected: 0.9x against 0.8x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.